Guide for patients & caregivers
What Does an HFE Gene Result (C282Y or H63D) Mean?
HFE gene result explained: C282Y homozygous vs carrier vs C282Y/H63D, why ferritin and transferrin saturation matter, venesection in outline and family testing.
Prepared with AI assistance and checked against the cited sources. No independent clinician review has been completed. How we prepare articles
What does an HFE gene result mean?
An HFE gene test looks for changes, mainly C282Y and H63D, linked to hereditary haemochromatosis, a condition in which the body slowly absorbs and stores too much iron. Two copies of C282Y (homozygous) carry the highest risk, a C282Y/H63D combination carries a much lower risk, and one copy alone usually means carrier status.
A gene result shows inherited risk, not current iron levels. Whether treatment is needed depends on iron blood tests and a clinician's assessment. This guide explains the terms; it cannot interpret your own report.
Symptoms to get checked sooner
Haemochromatosis usually develops slowly, and many people are found through blood tests before they have symptoms. The NHS lists later symptoms that can follow years of iron build-up. Contact a doctor promptly if any of these are new, and seek urgent care if they are severe or sudden.
- Yellow skin or whites of the eyes (jaundice). The NHS advises an urgent GP appointment or NHS 111 for this.
- Abdominal pain and swelling.
- Chest pain, shortness of breath, swelling in the hands or feet, or an irregular heartbeat. Chest pain or severe breathlessness needs emergency care.
- Excessive thirst and passing urine much more often.
- Severe joint pain and stiffness, or skin darkening.
C282Y homozygous, compound heterozygous or carrier: what is the difference?
Everyone has two copies of the HFE gene, one from each parent. The NHS explains that a person is only at risk of haemochromatosis if they inherit the faulty gene from both parents. NHS Genomics Education describes the common patterns:
- C282Y/C282Y (homozygous): the genotype most at risk of iron overload. It accounts for about 90% of clinical cases and is found in roughly 1 in 200 people of northern European background.
- C282Y/H63D (compound heterozygous): may lead to some iron build-up, but the risk of clinical haemochromatosis is much lower than with two C282Y copies.
- H63D/H63D: far less likely to cause clinical features.
- One C282Y copy (heterozygous): described as carrier status. The NHS says carriers will not develop haemochromatosis themselves but can pass the gene on.
If I have two copies, will I definitely get iron overload?
No. The NHS states that inheriting two faulty copies does not mean a person will definitely develop haemochromatosis, and only a small proportion do. NHS Genomics Education describes penetrance as incomplete, with variable expression. Raised iron markers on blood tests are more common than iron causing symptoms or organ damage.
MedlinePlus Genetics notes that factors such as dietary iron and alcohol can affect how the condition shows itself. Symptoms, when they occur, usually start between about 30 and 60. They tend to appear earlier in men and often after menopause in women.
Why do ferritin and transferrin saturation matter?
The gene test answers whether the risk is inherited. Iron blood tests answer whether iron has actually built up. The NHS describes transferrin saturation as showing how much iron in the blood is bound to transferrin, and serum ferritin as an estimate of the iron stored in the body.
NHS Genomics Education notes that a diagnosis needs evidence of iron overload, not the genotype alone. It gives guide thresholds of ferritin above 300 µg/L in men and above 200 µg/L in women, and transferrin saturation above 50% in men and above 45% in women. Laboratories and services may use different ranges, so read your values against your own report.
Ferritin is not specific to iron overload. MedlinePlus explains that inflammation, infection, liver disease, alcohol use and other conditions can also raise it. A high transferrin saturation with a normal ferritin raises a different question, covered in a separate guide on high iron saturation with normal ferritin.
If iron overload is confirmed, the NHS describes further checks for organ effects, mainly on the liver. These can include a liver scan or MRI, heart tests, and reviews for joints, diabetes and bone health.
What is venesection and how does it work?
Venesection (also called phlebotomy) is the main treatment for iron overload in haemochromatosis. The NHS describes it as similar to giving blood: about 500ml of blood is removed from a vein in the arm. The body then uses stored iron to make new red blood cells, which gradually lowers iron levels.
In outline, the NHS says treatment is often about weekly at first until iron levels are normal, which can take a year or more. After that, maintenance sessions are usually needed 2 to 4 times a year, often for life. The exact schedule is set by the care team using repeat blood tests. Medicines that remove iron (chelation) are used only in a small number of cases where venesection is not possible.
The NHS says major diet changes are not usually needed. Typical advice includes avoiding iron-fortified breakfast cereals, iron and vitamin C supplements, raw oysters and clams, and heavy drinking. Do not stop or change any prescribed medicine or supplement plan without talking to your clinician.
Should my family be tested?
Often, yes. The NHS advises anyone with a parent or brother or sister who has haemochromatosis to talk to a GP about blood tests, even without symptoms. NHS Genomics Education says it is important to clarify the genetic status of adult siblings and children of affected people. It adds that testing young children is unlikely to be useful, because the condition does not show before adulthood.
When two carriers have a child, the NHS explains there is a 1 in 4 chance the child inherits two faulty copies, a 1 in 2 chance the child is a carrier, and a 1 in 4 chance the child inherits neither. A genetics service can explain what a result means for each relative.
Questions to ask your clinician
Bring the gene report and your most recent iron results with dates.
- Which variants were found, and is my result homozygous, compound heterozygous or carrier?
- Do my ferritin and transferrin saturation show iron overload, or only risk?
- Do I need venesection now, or monitoring, and how often will iron be rechecked?
- Do I need tests of my liver, heart, joints or blood sugar?
- Which relatives should be offered testing, and how do I tell them?
- Is there anything in my diet, alcohol or supplements I should change?
How SameCase can help you prepare
On SameCase, patients and verified doctors share de-identified cases. Comparing similar HFE results, including the iron tests and follow-up plans others described, can help you shape questions for your appointment. Other people's cases cannot tell you whether you will develop iron overload or what treatment you need.
Sources and further reading
- NHS: Haemochromatosis causes, carriers and inheritance (reviewed March 2023)
- NHS: Haemochromatosis symptoms and when to see a GP (reviewed March 2023)
- NHS: Haemochromatosis diagnosis, ferritin and transferrin saturation (reviewed March 2023)
- NHS: Haemochromatosis treatment, venesection and diet (reviewed March 2023)
- NHS England Genomics Education Programme GeNotes: Hereditary haemochromatosis (reviewed March 2026)
- MedlinePlus Genetics: Hereditary hemochromatosis (updated February 2019)
- MedlinePlus: Ferritin blood test and causes of high ferritin (updated March 2025)
For patients & caregivers
Share your case and learn from others
Learn from doctors and other people's cases to find a way forward with your health problem. New cases are public immediately. Don't add names or identifying details.